Brief: Assembly Biosciences Presents New Data Highlighting Clinical Progress Of Core Inhibitor Programs

Assembly Biosciences

22/06/2022 14:22

June 22 (Reuters) - Assembly Biosciences Inc  ASMB.O :
    * ASSEMBLY BIOSCIENCES PRESENTS NEW DATA HIGHLIGHTING
CLINICAL
PROGRESS OF CORE INHIBITOR PROGRAMS AT EASL’S INTERNATIONAL
LIVER CONGRESS™ 2022

Source text for Eikon:  ID:nGNX6Ptpb 
Further company coverage:  ASMB.O 

 ((Reuters.Briefs@thomsonreuters.com;))